CDKN2A and neoplasm: The differential expression of CDKN2A was firstly assessed using the TIMER2 repository and the output revealed that except for PAAD and PCPG, all of the analyzed tumors with normal tissue for comparison exhibited a significant upregulation of CDKN2A in tumor tissue versus control (Figure 1A).